William P. Pfund

Development of a supersaturable SEDDS (S‐SEDDS) formulation of paclitaxel with improved oral bioavailability

Ping Gao, B.D. Rush, William P. Pfund et al. · Journal of Pharmaceutical Sciences · 2003 · 358 citations

Pharmaceutical Science, Improved Oral Bioavailability, Medicine +6

Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA.

Mark T. Muller, William P. Pfund, Veela B. Mehta et al. · The EMBO Journal · 1985 · 213 citations · Full text

Ribosomal Dna, Chromatin, Biosynthesis +6

Characterization of a novel polymorphic form of celecoxib

Guang Wei Lu, Michael Hawley, Mark E. Smith et al. · Journal of Pharmaceutical Sciences · 2005 · 96 citations

Combinatorial Chemistry, Medicinal Chemistry, Molecular Diversity +6

The conformation-sensitive immunoassay: A membrane based elisa system for identifying antibodies sensitive to alterations of protein conformation

William P. Pfund, James S. Bourdage · Molecular Immunology · 1990 · 17 citations

Elisa System, Biochemistry, Protein Folding +12

Development of 3D Dynamic Flow Model of Human Liver and Its Application to Prediction of Metabolic Clearance of 7-Ethoxycoumarin

Kyoungju Choi, William P. Pfund, Melvin E. Andersen et al. · Tissue Engineering Part C Methods · 2013 · 16 citations

Tissue Engineering, Engineering, Cell Culture +28